<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-0319</journal-id>
<journal-title><![CDATA[Revista Cubana de Enfermería]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Enfermer]]></abbrev-journal-title>
<issn>0864-0319</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-03192019000200002</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Buenas prácticas clínicas con el uso del Heberprot-P® en pacientes con úlcera del pie diabético]]></article-title>
<article-title xml:lang="en"><![CDATA[Good Clinical Practices in Heberprot-P ® Usage in Patients with Diabetic Foot Ulcer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jay Cordie]]></surname>
<given-names><![CDATA[Benito]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Hechavarria]]></surname>
<given-names><![CDATA[Zuzel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kindelán Mesa]]></surname>
<given-names><![CDATA[Leonid Marcel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cámbara Toro]]></surname>
<given-names><![CDATA[Yonaisi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Santiago de Cuba Policlínico Docente "Ramón López Peña" ]]></institution>
<addr-line><![CDATA[Santiago de Cuba ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Santiago de Cuba Policlínico "Armando García Aspurú" ]]></institution>
<addr-line><![CDATA[Santiago de Cuba ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-03192019000200002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-03192019000200002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-03192019000200002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La diabetes mellitus es una enfermedad crónica común, 50 % de las amputaciones no traumáticas de la extremidad inferior ocurren en diabéticos, 85 % de estas amputaciones están precedidas de una lesión del pie diabético.  Objetivo:  Describir los resultados del uso del Heberprot-P® en las úlceras del pie diabético.  Métodos:  Estudio descriptivo - transversal en el Policlínico "Ramón López Peña" de Santiago de Cuba de enero - diciembre 2015. Universo constituido por 19 pacientes diagnosticados con úlcera del pie diabético y se les administró Heberprot-P® intralesional. Se estudiaron las variables: sexo, edad, tipo de diabetes, clasificación de las lesiones según Wargner, dosis de tratamiento, miembro afectado y localización, reacciones adversas y desenlace del tratamiento.  Resultados: Predominaron los pacientes entre 50 y 59 años de edad (36,84 %), 52,60 % femenino. Las lesiones tratadas fueron Wagner II con prevalencia de diabetes tipo 2, según localización el grueso artejo para un 36,83 %, a 31,57 % de pacientes se les administró hasta 5 dosis de tratamiento, miembro inferior izquierdo el más afectado con 68,39 %, 89,48 % de los pacientes tuvieron cierre total.  Conclusiones: En el contexto de la práctica clínica habitual, y en la evolución de los pacientes tratados con Heberprot-P®, este continúa siendo un medicamento seguro y efectivo en el tratamiento de las úlceras del pie diabético, su utilización no debe verse como una terapia aislada, sino dentro de una estrategia de prevención diseñada a disminuir el efecto de los factores de riesgo modificables en pacientes diabéticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Diabetes mellitus is a common chronic disease. 50% of nontraumatic amputations of the lower limb occur in diabetic patients and 85% of these amputations are preceded by a diabetic foot injury.  Objective:  To describe the outcomes of Heberprot-P® usage in diabetic foot ulcers.  Methods:  A descriptive, cross-sectional study was carried out at Ramón López Peña Polyclinic in Santiago de Cuba, from January to December 2015. The study population consisted of 19 patients diagnosed with diabetic foot ulcer and who were administered intralesional Heberprot-P®. The variables studied were sex, age, type of diabetes, classification of the lesions according to Wargner, treatment dose, affected member and location, adverse reactions and treatment outcome.  Results:  Patients between 50 and 59 years of age (36.84%) and female participants (52.60%) predominated. The lesions treated were Wagner II, with prevalence of type 2 diabetes; depending on the location, the hallux accounted for 36.83%. 31.57% of patients were administered up to five doses of treatment. The lower left limb was the most affected (68.39%) and 89.48% of the patients had total closure.  Conclusions:  For the context of the usual clinical practice and for the evolution of patients treated with Heberprot-P®, this product continues to be a safe and effective medication in the treatment of diabetic foot ulcers. The use of this medicine should not be seen as an isolated therapy, but as part of a prevention strategy designed to reduce the effect of modifiable risk factors in diabetic patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes]]></kwd>
<kwd lng="es"><![CDATA[Heberprot-P®]]></kwd>
<kwd lng="es"><![CDATA[pie diabético]]></kwd>
<kwd lng="en"><![CDATA[diabetes]]></kwd>
<kwd lng="en"><![CDATA[Heberprot-P®]]></kwd>
<kwd lng="en"><![CDATA[diabetic foot]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quirantes Hernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[López Granja]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Curbelo Serrano]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Montano Luna]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Machado Leyva]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Quirantes Moreno]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La calidad de la vida del paciente diabético]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>2000</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amputation and the diabetic foot learning from a case study]]></article-title>
<source><![CDATA[British Journal of Community Nursing]]></source>
<year>2005</year>
<volume>10</volume>
<numero>^s12 Suppl</numero>
<issue>^s12 Suppl</issue>
<supplement>12 Suppl</supplement>
<page-range>18-24</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brem]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sheehan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Boulton]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence-based protocol for diabetic foot ulcers]]></article-title>
<source><![CDATA[Plast Reconstr Surg]]></source>
<year>2006</year>
<volume>117</volume>
<numero>^sSuppl 7</numero>
<issue>^sSuppl 7</issue>
<supplement>Suppl 7</supplement>
<page-range>193-209</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vuolo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Why people with diabetes suffer foot ulceration]]></article-title>
<source><![CDATA[Nurs Times]]></source>
<year>2007</year>
<volume>103</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>44-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Duarte]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beneficios de la intervención con ozonoterapia en pacientes con pie diabético neuroinfeccioso]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Hernández Carretero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Arpajón Peña]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gálvez Valcárcel]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Reynaldo Concepción]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jay Carbonell]]></surname>
<given-names><![CDATA[VG]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cubana Angiol Cir Vasc]]></source>
<year>2014</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jeffcoate]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lipsky]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Berendt]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Cavanagh]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Bus]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Un-resolved issues in the management of ulcers of the foot in diabetes]]></article-title>
<source><![CDATA[Diabet Med]]></source>
<year>2008</year>
<volume>25</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1380-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Montequín]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela Silva]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[OG]]></given-names>
</name>
<name>
<surname><![CDATA[Savigne]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Sancho Soutelo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rivero-Fernández]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers Multicenter, randomised, placebo-controlled, double-blind study]]></article-title>
<source><![CDATA[IntWound J]]></source>
<year>2009</year>
<volume>6</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>432-43</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Montequin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Santiesteban]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Experiencias en el uso del Heberprot-P en Venezuela. Reportes de casos del hospital Carlos Arvelo, Caracas. Infiltración del factor de crecimiento epidérmico. Un tratamiento eficaz para la úlcera del pie diabético]]></source>
<year>2009</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Elfos Scientiae]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuario estadístico 2015]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vejerano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Travieso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbilidad y mortalidad por pie diabético en nuestro servicio]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1990</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>142-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Rivero]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heberprot-P, una terapia eficaz en la prevención de la amputación en el pie diabético]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Llanes Barrios]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta Lapera]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cubana Ang Cirug Vasc]]></source>
<year>2009</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Herrera]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Montequín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El pie diabético]]></article-title>
<source><![CDATA[Generalidades del pie diabético]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García Herrera]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comportamiento de la diabetes mellitus y pronóstico de la lesión neuropática e infecciosa del diabético]]></article-title>
<source><![CDATA[Rev Méd Electrón.]]></source>
<year>2007</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Montequín]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Betancourt]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
<name>
<surname><![CDATA[Leyva-González]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[López Mola]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galán-Naranjo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Navas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer treatment up to complete wound closure]]></article-title>
<source><![CDATA[Int Wound J]]></source>
<year>2009</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-72</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco Pérez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las amputaciones de dedos abiertas y cerradas: su evolución en el pie diabético]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Valdés Pérez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Llanes Barrios]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Reynaldo Concepción]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Leonard]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cubana Ang Cir Vasc]]></source>
<year>2010</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-23</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classification]]></article-title>
<source><![CDATA[Diabetes Res ClinPract]]></source>
<year>2012</year>
<volume>95</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>358-63</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Margolis]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Malay]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffstad]]></surname>
<given-names><![CDATA[OJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006 to 2008: Data Points#1]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Data Points Publication Series Rockville (MD) ]]></publisher-loc>
<publisher-name><![CDATA[Agency for Healthcare Research and Quality (US)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinzur]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Slovenkai]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Trepman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[NN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for diabetic foot care Recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society]]></article-title>
<source><![CDATA[FootAnkleInt]]></source>
<year>2005</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>113-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero Fernández]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencias del Programa de atención integral a pacientes con pie diabético en el estado Zulia, Venezuela]]></article-title>
<source><![CDATA[Biotecnol Apl]]></source>
<year>2010</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallardo]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil epidemiológico del pie diabético]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Zangronis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Angiología]]></source>
<year>2004</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
